These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 1511428

  • 1. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro.
    Perry RR, Greaves BR, Rasberry U, Barranco SC.
    Cancer Res; 1992 Sep 01; 52(17):4608-12. PubMed ID: 1511428
    [Abstract] [Full Text] [Related]

  • 2. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan 01; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 3. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH, Singh SV.
    Cancer Res; 1992 Dec 01; 52(23):6666-70. PubMed ID: 1423311
    [Abstract] [Full Text] [Related]

  • 4. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC.
    Cancer Res; 1993 May 01; 53(9):2066-70. PubMed ID: 8097674
    [Abstract] [Full Text] [Related]

  • 5. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K, Shrieve DC.
    J Natl Cancer Inst; 1987 Oct 01; 79(4):811-5. PubMed ID: 3477662
    [Abstract] [Full Text] [Related]

  • 6. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E.
    Mol Pharmacol; 1996 Jun 01; 49(6):1012-20. PubMed ID: 8649339
    [Abstract] [Full Text] [Related]

  • 7. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC, Denekamp J, Minchinton AI.
    Radiat Res; 1985 Jun 01; 102(3):283-94. PubMed ID: 4070545
    [Abstract] [Full Text] [Related]

  • 8. Nonenzymatic reductive activation of 7-N-((2-([2-(gamma-L-glutamylamino)ethyl]dithio)ethyl))mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumor cells.
    Lee JH, Naito M, Tsuruo T.
    Cancer Res; 1994 May 01; 54(9):2398-403. PubMed ID: 8162587
    [Abstract] [Full Text] [Related]

  • 9. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
    Dusre L, Mimnaugh EG, Myers CE, Sinha BK.
    Cancer Res; 1989 Feb 01; 49(3):511-5. PubMed ID: 2535960
    [Abstract] [Full Text] [Related]

  • 10. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
    Peters RH, Jollow DJ, Stuart RK.
    Cancer Res; 1991 May 15; 51(10):2536-41. PubMed ID: 2021933
    [Abstract] [Full Text] [Related]

  • 11. Glutathione as a determinant of cellular response to doxorubicin.
    Lee FY, Vessey AR, Siemann DW.
    NCI Monogr; 1988 May 15; (6):211-5. PubMed ID: 3352767
    [Abstract] [Full Text] [Related]

  • 12. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
    Lambert PA, Kang Y, Greaves B, Perry RR.
    J Surg Res; 1998 Dec 15; 80(2):177-81. PubMed ID: 9878310
    [Abstract] [Full Text] [Related]

  • 13. Lack of a role of glutathione in cellular nonenzymatic activation of BMS-181174, a novel analogue of mitomycin C.
    Xia H, Pinto T, Hu X, Benson PJ, Zaren HA, Gupta V, Singh S.
    Cancer Res; 1996 Aug 01; 56(15):3495-8. PubMed ID: 8758917
    [Abstract] [Full Text] [Related]

  • 14. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U, Schorn H.
    Radiat Res; 1986 Mar 01; 105(3):351-69. PubMed ID: 3754339
    [Abstract] [Full Text] [Related]

  • 15. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
    Clark EP, Epp ER, Biaglow JE, Morse-Gaudio M, Zachgo E.
    Radiat Res; 1984 May 01; 98(2):370-80. PubMed ID: 6539482
    [Abstract] [Full Text] [Related]

  • 16. Modulation of glutathione level in cultured human melanoma cells.
    Karg E, Brötell H, Rosengren E, Rorsman H.
    Acta Derm Venereol; 1989 May 01; 69(2):137-41. PubMed ID: 2564231
    [Abstract] [Full Text] [Related]

  • 17. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA, Greene K, Ahmad S, Vistica DT.
    Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359
    [Abstract] [Full Text] [Related]

  • 18. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line].
    Bier H.
    Laryngorhinootologie; 1990 Jan 15; 69(1):16-20. PubMed ID: 2310456
    [Abstract] [Full Text] [Related]

  • 19. Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion.
    Andrews PA, Murphy MP, Howell SB.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6250-3. PubMed ID: 4063975
    [Abstract] [Full Text] [Related]

  • 20. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
    Berger SJ, Gosky D, Zborowska E, Willson JK, Berger NA.
    Cancer Res; 1994 Aug 01; 54(15):4077-83. PubMed ID: 8033140
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.